4.7 Article

Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma

Journal

JCI INSIGHT
Volume 4, Issue 22, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.127889

Keywords

-

Funding

  1. National Natural Science Foundation of China [81371022, 81570860, 81870665]
  2. Canadian Institutes for Health Research
  3. Canadian Cancer Society Research Institute
  4. Krembil Foundation
  5. Foundation Fighting Blindness Canada

Ask authors/readers for more resources

Von Hippel-Lindau (Vhl) protein inhibits hypoxia-inducible factor (Hif), yet its deletion in murine retina does not cause the extensive angiogenesis expected with Hif induction. The mechanism is unclear. Here we show that retinoblastoma tumor suppressor (Rb1) constrains expression of Hif target genes in the Vhl(-/-) retina. Deleting Rb1 induced extensive retinal neovascularization and autophagic ablation of photoreceptors in the Vhl(-/-) retina. RNA-sequencing, ChIP, and reporter assays showed Rb1 recruitment to and repression of certain Hif target genes. Activating Rb1 by deleting cyclin D1 induced a partial defect in the retinal superficial vascular plexus. Unexpectedly, removing Vhl suppressed retinoblastoma formation in murine Rb1/Rbl1-deficient retina but generated subretinal vascular growths resembling retinal angiomatous proliferation (RAP) and retinal capillary hemangioblastoma (RCH). Most stromal cells in the RAP/RCH-like lesions were Sox9(+), suggesting a Muller glia origin, and expressed Lgals3, a marker of human brain hemangioblastoma. Thus. the Rb family limit Hif target gene expression in the Vhl(-/-) retina, and removing this inhibitory signal generates new models for RAP and RCH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available